Stay updated with breaking news from Serum Institutes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
COVID In India: How many cases of COVID-19 has India logged in the last 24 hours? Is the country ready for a new coronavirus wave? Scroll down to know the top 10 developments. TheHealthSite.com
Serum Institute is already conducting a trial of its COVID-19 vaccine Covovax, a domestically produced version of Novavax's shot, in the 12-17 age group and has presented safety data for an initial...
Coronavirus News LIVE Updates: India has administered about 212 million doses, the most after China and the United States, but has given the necessary two doses to only about 3% of its 1.35 billion people.
Bharat Biotech’s Covaxin has been given the regular emergency use authorisation in public interest, putting it on a par with the approval granted to Serum Institute’s Covishield’s, V K Paul, member-health, Niti Aayog told reporters on Thursday. Health Secretary Rajesh Bhushan added that the government has renegotiated the price of vaccines at a much lower level than before, without sharing any further details. “Earlier price was Rs 200 per dose and Rs 210 with taxes. After that, the re-negotiated price is significantly lower than this.” Paul added: “Covaxin is now allowed for rest...
Bharat Biotechs Covaxin and Serum Institutes Covishield vaccines require a two-dose schedule to be administered through the intramuscular route